Amgen’s stock experienced a significant surge of more than 12% following the release of positive initial data on its experimental weight loss injection, MariTide. The market’s reaction to this news highlighted investor concerns about new competition in the weight loss drug industry, leading to decreases in the stock prices of current obesity medication players such
0 Comments
The cost of running a family office has surged in recent years, with the average annual expenditure now exceeding $3 million. This spike is attributed to the intense competition for top talent in the industry, which has driven up staffing expenses significantly. According to the J.P. Morgan Private Bank Global Family Office Report, wealthy families
0 Comments
The U.S. Department of Education recently announced that it will be transferring some student loan borrowers currently serviced by Mohela to different servicers. This change will impact more than 1 million borrowers under Mohela’s management. The Department of Education contracts with various companies to service federal student loans, including Mohela, Nelnet, and EdFinancial, paying them
0 Comments
CVS Health recently announced its first-quarter revenue and adjusted earnings, falling short of expectations and leading to a significant drop in share prices. The company reduced its full-year profit outlook due to higher medical costs impacting the U.S. insurance industry. These challenges caused shares to plummet by almost 18%, marking the worst day for the
0 Comments